Definium Therapeutics, Inc. Common Shares —— 季度财务报表 (NASDAQ:DFTX)

展开完整图表

Financials

概览声明统计

每季度年度

Market Capitalization 2.21 B
Employee 106
Founded 2010
CEO Robert Barrow
Website www.definiumtx.com
Headquarter British Columbia, Canada
FIGI BBG00F13HYQ7
Industry Technology

总收入

净利润

每股基本收益（基本 EPS）

总债务

自由现金流

现金及现金等价物

2.21 B 市值

Definium Therapeutics Inc

Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.